Day: November 28, 2019
28. nóvember 2019340 M.KR. AFGANGUR VERÐI Á REKSTRI MOSFELLSBÆJAR ÁRIÐ 2020Áformað er að bæjarsjóður verði rekinn með 340 m.kr. afgangi á næsta ári.Gert er ráð fyrir þessum góða afgangi af rekstrinum þrátt fyrir að stefnt sé að því að lækka bæði leikskólagjöld og álagningarprósentur fasteignagjalda á árinu.Áætluð rekstrargjöld Mosfellsbæjar á árinu 2020 eru um 5,5 milljarðar króna og áætlaður launakostnaður um 6,3 milljarðar króna.Áætlað er að skuldaviðmið nemi 79% í árslok.Fjárhagsáætlun Mosfellsbæjar fyrir árið 2020 sem samþykkt var á bæjarstjórnarfundi þann 27. nóvember gerir ráð fyrir að tekjur verði 13.380 m.kr., gjöld án fjármagnsliða 12.412 m.kr., fjármagnsliðir 628 m.kr. og að rekstrarafgangur verði 340 m.kr.Mikil uppbygging á sér nú stað í Mosfellsbæ. Fyrirhugað er að framkvæma fyrir 2.970 m.kr. á næsta ári sem að mestu rennur...
Inscape Corporation Will Host a Teleconference Call to Review the Second Quarter Fiscal 2020 Financial Results
Written by Customer Service on . Posted in Public Companies.
HOLLAND LANDING, Ontario, Nov. 28, 2019 (GLOBE NEWSWIRE) — (TSX:INQ) Inscape Corporation will release its second quarter financial results after the close of business on Thursday, December 12, 2019. Brian Mirsky, Chief Executive Officer and Aziz Hirji, Chief Financial Officer will host a teleconference call on Friday, December 13, 2019 at 8:30AM EST to briefly review the results and respond to any questions.To participate, please call 1-800-920-4316 five minutes before the start time of 8:30 AM EST. (Reservation Number 21934709) A taped rebroadcast will be available from December 13, 2019 after 10:30 AM EST until 11:59 PM EST on January 13, 2020. To access the rebroadcast, please dial 1-800-558-5253. (Reservation Number 21934709)FOR FURTHER INFORMATION, PLEASE CONTACT:Inscape CorporationAziz HirjiChief Financial Officer(905) ...
On “Grindeks” results in the first nine months of 2019
Written by Customer Service on . Posted in Public Companies.
“Grindeks” profit in the first nine months of 2019 increases by 17% and reaches 8.9 million euroToday, on November 28, JSC “Grindeks” submitted the non-audited consolidated financial statements of the first nine months of 2019 to Nasdaq Riga. Non-audited financial results indicate that in the first nine months of 2019 the Group’s profit, attributable to shareholders of the parent company, has reached 8.9 million euro. The profit has increased by 1.3 million euro or 17% in comparison to the first nine months of 2018. The turnover of the first nine months of 2019 was 106.6 million euro, and it has increased by 4.1 million euro or 4% in comparison to the first nine months of 2018.JSC “Grindeks” Chairman of the Board Juris Bundulis: “In the first nine months of 2019 we have increased our productivity, improved the Group’s net profit margin...
Par „Grindeks” 2019. gada deviņu mēnešu rezultātiem
Written by Customer Service on . Posted in Public Companies.
2019. gada deviņos mēnešos „Grindeks” peļņa pieaug par 17% un sasniedz 8,9 milj. eiroŠodien, 28. novembrī, akciju sabiedrības „Grindeks” „Nasdaq Riga” iesniegtie 2019. gada deviņu mēnešu nerevidētie konsolidētie finanšu pārskati liecina, ka koncerna peļņa, kas attiecināma uz mātes sabiedrības akcionāriem, ir sasniegusi 8,9 milj. eiro. Salīdzinot ar 2018. gada deviņiem mēnešiem, peļņa ir palielinājusies par 1,3 milj. eiro vai par 17%. Koncerna apgrozījums 2019. gada deviņos mēnešos bija 106,6 milj. eiro, kas ir par 4,1 milj. eiro vai par 4% vairāk nekā 2018. gada deviņos mēnešos.AS „Grindeks” valdes priekšsēdētājs Juris Bundulis: „2019. gada deviņos mēnešos esam paaugstinājuši produktivitāti, uzlabojuši koncerna neto peļņas rentabilitāti un sasnieguši 8,9 milj. eiro peļņu. Tas uzņēmuma attīstībai dod pozitīvu efektu, kuru es uzskatu par...
Major shareholder announcement
Written by Customer Service on . Posted in Public Companies.
Orphazyme A/SCompany announcement No. 30/2019 Company Registration No. 32266355Copenhagen, Denmark, November 28, 2019 – Orphazyme A/S (ticker: ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, hereby announces the receipt of notification pursuant to Section 38 of the Danish Capital Markets Act from Danske Bank A/S that Danske Bank as of November 27, 2019 holds a total 999,606 shares in the Company, corresponding to 5.00% of the share capital and that Danske Bank as of November 27, 2019 controls 7.53% of the voting rights in the Company.Danske Bank A/S’ shareholding consists of a 4.84%...
Telo Genomics Announces Grant of Stock Options
Written by Customer Service on . Posted in Public Companies.
TORONTO, Nov. 28, 2019 (GLOBE NEWSWIRE) — Telo Genomics Corp. (TSX-V: TELO) (the “Company” or “TELO”) announces that it has granted incentive stock options to various directors, officers, employees and consultants of the Company to purchase up to an aggregate of 2,100,000 common shares of the Company pursuant to the Company’s stock option plan. The stock options are exercisable at a price of $0.15 per share for a period of five years. The stock option grant is subject to TSX Venture Exchange approval.For further information, please contact:Hugh RogersChairman416-673-8487info@telodx.comMaRS Centre, South Tower, 101 College Street, Suite 200, Toronto, ON, M5G 1L7www.telodx.comNeither the TSX Venture Exchange nor its Regulation Services Provider (as such term is defined in the policies of the TSX Venture Exchange) accepts responsibility...
Scanfil Oyj: Johdon liiketoimet
Written by Customer Service on . Posted in Public Companies.
SCANFIL OYJ JOHTOHENKILÖIDEN LIIKETOIMET 28.11.2019 klo 15.45Scanfil Oyj: Johdon liiketoimetLiiketoimien yksityiskohtaiset tiedot(1): Volyymi: 20 000 Yksikköhinta: 0Liiketoimien yhdistetyt tiedot(1): Volyymi: 20 000 Keskihinta: 0SCANFIL OYJ
Scanfil plc: Managers’ transactions
Written by Customer Service on . Posted in Public Companies.
SCANFIL PLC MANAGERS’ TRANSACTIONS 28 NOVEMBER 2019 3:45 P.M.Scanfil plc: Managers’ transactionsTransaction details(1): Volume: 20,000 Unit price: 0Aggregated transactions(1): Volume: 20,000 Volume weighted average price: 0
Cartier Resources Grants Stock Options
Written by Customer Service on . Posted in Public Companies.
VAL-D’OR, Quebec, Nov. 28, 2019 (GLOBE NEWSWIRE) — Cartier Resources Inc. (TSX-V: ECR) (the “Company”) announces that the Board of Directors granted, on November 27, 2019, a total of 1,450,000 stock options to directors and officers and to one employee of the Company. Pursuant to the terms of the Company’s stock option plan, each option entitles the holder thereof to purchase one common share of the Company at a price of $0.125 per share until no later than November 26, 2024.Contact:Philippe CloutierPresident and CEOCartier Resources Inc.Telephone: (819) 874-1331Toll free: 877 874-1331Fax: (819) 874-3113The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this press release.
Ressources Cartier octroie des options d’achats d’actions
Written by Customer Service on . Posted in Public Companies.
VAL-D’OR, Québec, 28 nov. 2019 (GLOBE NEWSWIRE) — Ressources Cartier Inc. (TSX-V: ECR) (la « Société ») annonce que le conseil d’administration de la Société a autorisé, le 27 novembre 2019, l’octroi d’un total de 1 450 000 options d’achat d’actions aux administrateurs et dirigeants et à un employé de la Société. En conformité avec le régime d’options d’achat d’actions, chacune des options octroyées permettra au détenteur de souscrire à une action ordinaire de la société au prix de 0,125 $ l’action jusqu’au plus tard le 26 novembre 2024.Contact :Philippe CloutierPrésident et chef de la directionRessources Cartier Inc.Téléphone : (819) 874-1331Sans Frais : 877 874-1331Télécopieur : (819) 874-3113La Bourse de croissance TSX n’assume aucune responsabilité quant à la pertinence ou à l’exactitude de ce communiqué.